HighMark Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $184K | Hold |
21,696
| – | – | 0.09% | 77 |
|
|
2025
Q1 | $174K | Hold |
21,696
| – | – | 0.1% | 60 |
|
|
2024
Q4 | $195K | Hold |
21,696
| – | – | 0.11% | 56 |
|
|
2024
Q3 | $159K | Sell |
21,696
-69,500
| -76% | -$509K | 0.09% | 79 |
|
|
2024
Q2 | $521K | Buy |
91,196
+16,000
| +21% | +$91.4K | 0.31% | 39 |
|
|
2024
Q1 | $377K | Buy |
75,196
+2,197
| +3% | +$11K | 0.23% | 44 |
|
|
2023
Q4 | $656K | Buy |
72,999
+13,000
| +22% | +$117K | 0.48% | 23 |
|
|
2023
Q3 | $466K | Sell |
59,999
-2,500
| -4% | -$19.4K | 0.39% | 27 |
|
|
2023
Q2 | $605K | Sell |
62,499
-2,000
| -3% | -$19.4K | 0.45% | 24 |
|
|
2023
Q1 | $707K | Buy |
64,499
+27,000
| +72% | +$296K | 0.55% | 24 |
|
|
2022
Q4 | $162K | Hold |
37,499
| – | – | 0.12% | 58 |
|
|
2022
Q3 | $282K | Hold |
37,499
| – | – | 0.24% | 32 |
|
|
2022
Q2 | $377K | Hold |
37,499
| – | – | 0.3% | 31 |
|
|
2022
Q1 | $464K | Sell |
37,499
-13,000
| -26% | -$161K | 0.31% | 30 |
|
|
2021
Q4 | $1.16M | Sell |
50,499
-70
| -0.1% | -$1.6K | 0.73% | 18 |
|
|
2021
Q3 | $1.12M | Buy |
50,569
+3,215
| +7% | +$71.1K | 0.82% | 16 |
|
|
2021
Q2 | $614K | Buy |
+47,354
| New | +$614K | 0.45% | 21 |
|
|
2021
Q1 | – | Sell |
-16,266
| Closed | -$225K | – | 477 |
|
|
2020
Q4 | $225K | Hold |
16,266
| – | – | 0.19% | 40 |
|
|
2020
Q3 | $240K | Sell |
16,266
-750
| -4% | -$11.1K | 0.22% | 39 |
|
|
2020
Q2 | $277K | Hold |
17,016
| – | – | 0.3% | 32 |
|
|
2020
Q1 | $246K | Sell |
17,016
-300
| -2% | -$4.34K | 0.3% | 28 |
|
|
2019
Q4 | $350K | Buy |
+17,316
| New | +$350K | 0.37% | 23 |
|